North America Digital Health Market Report by Technology, Component, Application, End Use, Countries and Company Analysis, 2026-2034

North America Digital Health Market Size and Forecast 2026-2034

North America Digital Health Market is expected to reach US$ 434.41 Billion by 2034 from US$ 103.09 Billion in 2025, with a CAGR of 17.33% from 2026 to 2034. Rapid digitalization, rising chronic disease management needs, expanding telehealth, artificial intelligence adoption, connected devices, interoperability initiatives, and growing patient demand for convenient, personalized, data-driven healthcare are accelerating North America’s digital health industry.

North America Digital Health Industry: Technology-Led Healthcare Transformation

North America’s digital health industry has evolved into a broad healthcare technology ecosystem encompassing telehealth, mobile health applications, electronic health records, remote patient monitoring, healthcare software, connected medical devices, artificial intelligence, digital therapeutics, and patient engagement platforms. The United States represents the region’s largest technology and investment center, supported by advanced healthcare infrastructure, substantial technology spending, venture capital activity, and strong participation from healthcare providers, insurers, pharmaceutical companies, and technology firms. In 2026, U.S. digital health investment continued to attract substantial capital, with AI increasingly influencing funding and product development priorities.

Healthcare providers across North America are increasingly using digital platforms to improve access, coordinate care, monitor patients remotely, and manage chronic conditions. Telehealth and remote monitoring have become important components of technology-enabled care, while connected devices can transmit physiological information such as glucose, blood pressure, weight, and oxygen levels directly to providers. In the United States, CMS expanded and refined telehealth and remote-monitoring policies for 2026, including changes affecting Medicare telehealth services and remote therapeutic monitoring. Canada is similarly strengthening digital connectivity. In 2024, 92% of Canadian healthcare providers reported access to a digital health system, although only 52% used such systems to share patient information electronically outside their primary practice.

Artificial intelligence, interoperability, and patient-centric applications are expected to remain central to industry development. The U.S. FDA reported more than 1,600 AI-enabled medical devices authorized for marketing by September 2026, demonstrating the expanding role of AI-supported healthcare technologies. Canada is investing in connected health infrastructure, including a C$100 million federal investment in the VITAL health data platform, while Mexico continues to promote telemedicine to extend specialist healthcare access across geographically dispersed populations. Across the region, digital health providers are therefore focusing on interoperable platforms, remote care, chronic disease management, predictive analytics, consumer applications, and secure health-data exchange.

Recent Developments in North America Digital Health Market

• In February 2025, Teladoc Health announced the introduction of a new AI-powered mental health platform in the United States. This platform is intended to simplify provider matching based on patient profiles and customize care regimens.
• In January 2025, Apple Health unveiled a brand-new blood pressure monitoring function included into the Apple Watch Series 9 with the goal of assisting patients with hypertension by providing real-time alerts and integrating with EHR systems.

Growth Drivers for the North America Digital Health Market

Artificial Intelligence and Connected Care: Primary Expansion Catalyst

Artificial intelligence is becoming an increasingly important component of North America’s digital health ecosystem. Healthcare organizations are adopting AI-enabled clinical decision support, diagnostic assistance, predictive analytics, automated documentation, patient communication tools, and workflow applications. The FDA reported more than 1,600 AI-enabled medical devices authorized for marketing in the United States by September 2026, illustrating the growing commercialization of AI within clinical environments. Beyond diagnosis, AI can analyze large volumes of healthcare information generated through electronic records, imaging, wearables, remote monitoring, and laboratory systems. Connected devices further expand the volume of real-world patient data available for clinical management. CMS recognizes remote patient monitoring using internet-connected devices that transmit physiological information such as glucose, blood pressure, and weight to healthcare providers. As hospitals and digital-health companies seek productivity improvements, earlier intervention, personalized treatment, and more efficient resource allocation, demand for AI-enabled software, analytics platforms, connected devices, and digital clinical workflows is increasing across North America.

Virtual Healthcare and Remote Monitoring Broaden Patient Access

Telehealth and remote patient monitoring are expanding digital health adoption by allowing healthcare providers to deliver selected services beyond traditional clinical settings. This is particularly relevant for chronic disease management, behavioral health, post-acute monitoring, rural healthcare, and patients requiring frequent follow-up. In the United States, CMS continues to maintain and update Medicare telehealth policies, while its 2026 physician fee schedule introduced changes intended to streamline the process for adding services to the Medicare Telehealth Services List. Remote patient monitoring also provides a structured mechanism through which connected devices transmit patient-generated health information to clinicians for treatment and management. Canada is simultaneously expanding virtual care and connected-care capabilities through national interoperability initiatives. Mexico is using telemedicine to address specialist shortages, geographic dispersion, and uneven access to healthcare resources. Together, these developments are increasing the addressable population for digital consultations, monitoring platforms, mobile applications, connected devices, and virtual chronic-care programs.

Interoperability and Health-Data Infrastructure Support Market Expansion

Interoperability is increasingly shaping North America’s digital health investment priorities because healthcare information remains distributed among hospitals, physicians, laboratories, pharmacies, insurers, and consumer applications. In the United States, HHS has emphasized nationwide interoperability and data liquidity, while CMS has highlighted progress in health-data exchange, modern interoperability standards, and patient access to digital health applications. Canada faces a similar requirement. Statistics Canada reported that insufficient integration between digital health systems was the most frequently identified barrier to electronically sharing patient information among providers. The Canadian Core Data for Interoperability and related FHIR-based standards are intended to facilitate standardized information exchange across healthcare systems. Investments in interoperability create opportunities for electronic health records, APIs, health-information exchanges, data platforms, analytics, and patient applications. As healthcare organizations seek connected longitudinal patient records, demand for secure data infrastructure and interoperable software is expected to remain a major contributor to digital health expansion.

Challenges in the North America Digital Health Market

Data Privacy, Cybersecurity, and Regulatory Complexity

Digital health companies handle highly sensitive information, including medical histories, diagnostic results, prescriptions, biometric measurements, and behavioral information. Protecting these datasets requires strong cybersecurity, access controls, encryption, consent mechanisms, and governance procedures. Regulatory requirements can also differ according to the technology, healthcare application, jurisdiction, and intended use. In the United States, software functions may fall under different regulatory categories depending on whether they meet the definition of a medical device. The FDA’s January 2026 clinical decision-support software guidance clarified distinctions between certain non-device clinical decision-support functions and software functions subject to medical-device policies. Digital-health platforms also face growing scrutiny over how consumer health information is collected, shared, and monetized. In Canada and Mexico, organizations must additionally navigate national and regional healthcare structures. Consequently, compliance costs, cybersecurity investment, data governance, regulatory interpretation, and cross-border data management can increase development timelines and operating complexity.

Fragmented Healthcare Systems and Uneven Digital Adoption

North America has sophisticated healthcare technology infrastructure, but adoption remains uneven among providers, regions, patient groups, and healthcare organizations. Differences in provider resources, broadband access, digital literacy, reimbursement structures, legacy systems, and technology budgets can affect the implementation of digital health solutions. Canada provides an example of this challenge: although 92% of healthcare providers reported access to a digital health system in 2024, 78% experienced at least one barrier to electronically sharing patient information outside their practice. Mexico faces additional geographic and infrastructure challenges, with its health authorities identifying specialist shortages, resource limitations, centralization, and difficult terrain as factors affecting healthcare access. Integration with legacy electronic health records can also require significant investment and technical customization. Smaller healthcare organizations may face greater financial and staffing constraints than large hospital systems. These disparities can slow deployment, create inconsistent user experiences, and limit the scalability of digital-health platforms across the entire region.

United States Digital Health Market: Scale, Innovation, and Investment

The United States represents the largest digital health market within North America, supported by extensive healthcare expenditure, advanced medical infrastructure, technology companies, venture capital, pharmaceutical organizations, insurers, and large healthcare systems. Major adoption areas include telehealth, remote patient monitoring, electronic health records, AI-enabled medical devices, digital therapeutics, healthcare analytics, patient engagement applications, and clinical workflow software. U.S. digital health funding remained strong during 2026, with AI contributing significantly to investment activity. Regulatory development is also shaping the market. The FDA launched its TEMPO pilot for selected digital health devices, while CMS continued refining telehealth and remote-monitoring policies. The United States also has an extensive interoperability ecosystem, with HHS and CMS emphasizing data liquidity, health-information exchange, and patient access. These conditions support continued development of digital healthcare platforms across clinical, consumer, and chronic-care applications.

Canada Digital Health Market: Building a Connected National Ecosystem

Canada’s digital health market is developing around connected care, electronic health information, virtual healthcare, interoperability, remote monitoring, and patient-facing applications. Healthcare organizations increasingly use electronic medical records and digital platforms, with Statistics Canada reporting that 92% of healthcare providers had access to a digital health system in 2024. However, information exchange remains incomplete, creating opportunities for interoperability platforms and standardized data infrastructure. The federal government introduced the Connected Care for Canadians Act in 2026 to accelerate interoperability standards and address information blocking. Canada also announced C$100 million for the VITAL health-data platform, intended to securely connect hospital data and support healthcare research and innovation. Digital-health demand is therefore being supported by virtual care, chronic disease management, health-data modernization, provider coordination, and government-backed interoperability initiatives across provincial and territorial healthcare systems.

Mexico Digital Health Market: Telemedicine Extending Healthcare Reach

Mexico’s digital health market is increasingly centered on telemedicine, digital clinical tools, electronic health information, patient education, and remote access to specialist services. The country’s geographic scale, uneven distribution of medical specialists, healthcare resource limitations, and concentration of services in urban centers create opportunities for technology-enabled care. Mexico’s government identifies telesalud as an important mechanism for improving access to specialized medical services across dispersed populations. In May 2026, the National Institute of Medical Sciences and Nutrition reported an integrated digital-health strategy incorporating telemedicine, healthcare-worker training, professional tele-assistance, patient education, and digital tools for clinical follow-up. Growth opportunities extend across virtual consultations, remote monitoring, mobile applications, digital records, hospital information systems, and patient engagement platforms. Adoption is expected to vary by region according to connectivity, healthcare infrastructure, digital literacy, provider availability, and investment capacity.

mHealth Market: Mobile Platforms Bringing Care Closer

Mobile health, or mHealth, represents a significant component of North America’s digital health ecosystem through smartphone applications, connected wearables, medication-management tools, fitness platforms, symptom monitoring, appointment applications, patient portals, and chronic disease-management solutions. The widespread availability of smartphones and connected devices allows consumers to monitor selected health parameters and communicate information with healthcare providers. mHealth applications are increasingly integrated with wearable sensors and remote monitoring platforms, creating continuous streams of patient-generated information. Diabetes management, cardiovascular monitoring, mental wellness, medication adherence, fitness, and preventive health are important application areas. The segment also benefits from broader interoperability initiatives that make it easier for applications to access and exchange health information. In the United States, CMS recognizes remote monitoring based on connected devices that transmit physiological data to providers. As consumers increasingly seek convenient, personalized, and digitally enabled healthcare experiences, mHealth platforms are positioned across both clinical and direct-to-consumer healthcare models.

Software Market: Digital Infrastructure for Modern Healthcare

Software forms the operational backbone of North America’s digital health industry, supporting electronic health records, hospital information systems, clinical decision support, telehealth platforms, healthcare analytics, revenue-cycle management, patient engagement, scheduling, e-prescribing, and remote monitoring. Increasing AI adoption is creating additional demand for software capable of processing clinical information, generating insights, supporting workflows, and assisting healthcare professionals. The FDA issued updated clinical decision-support software guidance in January 2026, clarifying how certain software functions are treated under medical-device regulations. Interoperability is another major software opportunity, with FHIR-based APIs and standardized data frameworks supporting information exchange between healthcare applications. Cloud deployment, subscription-based software, cybersecurity, analytics, and integration services are expanding the commercial opportunity. Healthcare organizations are increasingly seeking scalable platforms that can connect fragmented systems while reducing administrative workload and improving access to actionable patient information.

Diabetes Market: Technology-Enabled Chronic Disease Management

Diabetes represents a major digital-health application because effective management requires continuous monitoring, medication adherence, lifestyle management, clinical follow-up, and timely intervention. Digital health technologies include continuous glucose monitors, blood-glucose meters, connected insulin pens, insulin pumps, automated insulin delivery systems, mobile applications, digital coaching, remote monitoring platforms, and diabetes-management software. The American Diabetes Association identifies CGMs, insulin pumps, connected pens, automated insulin delivery systems, and self-management software as important components of modern diabetes technology. In the United States, CMS also supports remote monitoring models involving digitally transmitted glucose and other physiological information. Digital diabetes solutions can generate continuous or frequent patient data that supports treatment decisions and self-management. Demand is being reinforced by the growing need for chronic disease management, personalized care, remote follow-up, connected devices, and technology-assisted lifestyle interventions across North America.

Patients Market: Growing Consumer Participation in Digital Care

Patients are becoming increasingly active participants in North America’s digital health ecosystem as healthcare delivery shifts toward convenient, connected, and personalized models. Digital-health users include individuals accessing teleconsultations, patient portals, mobile health applications, remote monitoring, digital therapeutics, online health information, wearable devices, and virtual chronic-care programs. Patients with diabetes, cardiovascular conditions, respiratory disorders, mental health needs, and other chronic diseases represent important user groups because digital tools can support recurring monitoring and communication with providers. Remote patient monitoring enables patients to collect physiological information through connected devices and transmit it to healthcare professionals for clinical management. Patient demand is also encouraging providers to improve digital appointment systems, electronic access to medical records, medication management, and communication platforms. As interoperability improves, patients may increasingly expect health information to move between providers and care settings. This growing emphasis on patient engagement is expanding the addressable market for consumer-facing digital health solutions.